Physician profile
Sarah E Harrison
NPI 1700267358
$2,213.62
in general payments reported to CMS, 2019-2025
25 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2020: $213 · 2021: $116 · 2022: $86.69 · 2023: $617 · 2024: $304 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,526.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.17 | 2019-2023 | |
| Biogen, INC. | $187.70 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $174.22 | 2023-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $166.37 | 2020-2025 | |
| Millicent US INC | $161.62 | 2022-2025 | Intrarosa, Femring, Femlyv |
| Pfizer INC. | $157.46 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $149.27 | 2022-2025 | |
| Exeltis, USA INC. | $127.03 | 2021-2025 | Slynd |
| Myriad Women'S Health, INC. | $110.72 | 2023 | Myrisk |
| Medical Device Business Services, INC. | $100.14 | 2020 | |
| Gauss Surgical INC. | $99.87 | 2019 | |
| Exact Sciences Corporation | $94.20 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $62.51 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Organon LLC | $55.68 | 2022-2023 | Nexplanon, Nuvaring |
| Daiichi Sankyo INC. | $48.55 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $46.75 | 2019 | |
| Baxter Healthcare | $44.42 | 2023 | Tisseel |
| Novo Nordisk INC | $38.76 | 2023 | Rybelsus, Ozempic |
| Coopersurgical, INC. | $33.63 | 2021-2024 | Paragard T 380a |
| Medtronic, INC. | $23.49 | 2024 | Truclear |
| Therapeuticsmd, INC. | $18.89 | 2020 | |
| Shield Therapeutics INC | $17.68 | 2025 | |
| Lilly USA, LLC | $16.15 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $12.45 | 2020 | |
| Mission Pharmacal Company | $11.89 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.